<DOC>
	<DOCNO>NCT03090425</DOCNO>
	<brief_summary>In hitherto ill-defined proportion patient inflammatory/familial cardiomyopathy , phenotype dilative cardiomyopathy ( DCM ) assume endstage multifactorial etiopathogenetic pathophysiology . Precipitating factor include enhanced autoimmunity , predisposition viral infection , environmental factor addition specific 'genetic background ' individual patient . It unresolved , whether susceptibility immunologically mediate myocardial damage reflect presence genetic risk factor share autoimmune disease , cardio-specific individual predisposing factor . Aims project search genetic link oredisposition autoimmune diseases patient familial / inflammatory DCM .</brief_summary>
	<brief_title>Inflammatory/Familial Dilated Cardiomyopathy : Is There Link Autoimmune Diseases ? TP9a</brief_title>
	<detailed_description>Epidemiological investigation patient autoimmune disease show addition specific genetic alteration secondary inducing factor responsible onset disease , may lead different phenotype autoimmune disease single family . The work hypothesis derive inflammatory DCM endstage autoimmune cardiac disease go along activation succeptibility gene , common autoimmune disease . Original aim project : - inclusion patient dilate cardiomyopathy ( ejection fraction &lt; 45 % , leave ventricular enddiastolic diameter &gt; 56mm ) addition - inclusion relevant data regard possible familial , infectious autoimmune etiology disease . A questionnaire add CRFs , order ascertain data regard possible familial history patient cardiac disease , also autoimmune disorder . A pedigree patient draw . Data regard possible infectious inflammatory etiology disease available investigation endomyocardial biopsy peripheral blood . All data include CRF . Derived data base , biopsy serum bank , aim project search genetic link genetic predisposition autoimmune diseases patient DCM , especially inflammatory disease . To reach aim , peripheral blood include patient send biomaterial bank Berlin . DNA extract peripheral blood investigate detection genetic abnormality gene structural protein , know associated DCM . In addition , screen do several candidate gene endomyocardial biopsy patient DCM use microchip technology investigation polymorphism HLA class II DQ locus patient cohort . Data Investigation correlate clinical outcome patient , clinically follow total 10 year . Right 10 year follow-up ongoing .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Patients 18 70 year age include leave ventricular ejection fraction 45 % leave ventricular enddiastolic diameter &gt; 56 mm estimate echocardiography evidence significant valve disease . Coronary artery disease ( &gt; 50 % diameter luminal stenosis one epicardial vessel ) exclude patient mean coronary angiography . Moreover , patient exclude study demonstrate one follow parameter : peripartum cardiomyopathy , history myocardial infarction , severe systemic hypertension , alcohol abuse , drug dependency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>